Free Case Evaluation
With Us

Tag Archives: Fatally flawed

2 TYPES OF HIP  replacement total and resurfacing

FDA Follows Industry Lead to Shorten Time to Market

By Mesh Medical Device Newsdesk |

October 30, 2012 ~    The FDA has issued the new rules for medical device makers to speed up the time it takes for medical devices to make it to market. Earlier this year industry agreed to pay $595 million over 5 years to the FDA as part of its operating budget. In exchange, [continue reading…]

Gynecare Prolift, West Coast Medical Resources

Four J&J Vaginal Meshes Named – Will Be Removed from Market

By Mesh Medical Device Newsdesk |

June 5, 2012 ~ There is now more detailed information about the move by Johnson & Johnson (J&J) to stop the sale of four vaginal mesh implants. The four named meshes are: TVT Secur Prosima Pelvic Floor Repair System Prolift Pelvic Floor Repair System   Prolift MTM Pelvic Floor Repair System These are the [continue reading…]

Mesh after removal

ProPublia: Four Medical Devices that Bypassed FDA Scrutiny

By Mesh Medical Device Newsdesk |

May 10, 2012 ~ ProPublica, an independent journalism organization, reports on four medical devices that are among the thousands pushed into the marketplace every year that do not undergo Food and Drug Administration (FDA) scrutiny. The bottom line – medical devices are big business bringing over $100 billion-a-year to the industry, giving industry the [continue reading…]

Consumers Union Safe Patient project logo 218

Consumer Reports Campaign email Alerts Million About Defective Medical Devices

By Mesh Medical Device Newsdesk |

MARCH 12, 2012 ~ How bad are medical devices approved by the U.S. Food and Drug Administration? Reuters reports (here) that Consumer Reports believes they are very bad. The president of the 76-year-old publication wrote in an email to 1 million subscribers this year that, “The implant that fixed your knee or your heart [continue reading…]


FDA Denies Legal Group Seeking to Ban IOM Recommendations

By Mesh Medical Device Newsdesk |

March 7, 2012 ~ Bloomberg BNA reported (here) that the Washington Legal Foundation (WLF), had its petition rejected by the Food and Drug Administration February 21 after the industry-tied group tried to have the recommendation of an expert scientific panel barred from FDA consideration and implementation. The WLF is made up of corporate inside-the-beltway [continue reading…]

© 2016 Mesh Newsdesk. All rights reserved.
This news website is designed by